(1)
Biologics and Small Molecules Treatment for Moderate-to-Severe Atopic Dermatitis Patients With Comorbid Conditions and Special Populations: An Italian Perspective. Dermatol Reports 2023, 16 (2). https://doi.org/10.4081/dr.2023.9839.